MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)
$527.69 0.58 (0.11%)
Analysed MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) News Sources
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
21-04-2026
yahoo.com
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
16-04-2026
fool.com
Is Madrigal Pharmaceuticals (MDGL) Still Attractively Priced After Its 20% Monthly Surge?
11-04-2026
yahoo.com
Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug
27-03-2026
yahoo.com
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
27-03-2026
yahoo.com
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
27-03-2026
yahoo.com
Is It Too Late To Consider Madrigal Pharmaceuticals (MDGL) After Recent Share Price Surge?
27-03-2026
yahoo.com
Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?
26-03-2026
yahoo.com
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
26-03-2026
yahoo.com
ALT Pemvidutide Explained: What Makes It Different in MASH
26-03-2026
yahoo.com
What is the current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is $527.69.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) absolute price change since previous trading day?
The absolute price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is $0.58.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) percentage price change since previous trading day?
The percentage price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is 0.11%.
What is the most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is .
SEC-8K** Filing Available For MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.